CBAN Insider Purchase: CFO Derek Shelnutt Acquires 25 Shares

Rhea-AI Filing Summary

COLONY BANKCORP, INC. (CBAN) filing shows an insider purchase by CFO Derek Shelnutt. The report discloses a 09/23/2025 acquisition of 25 shares of common stock at a reported price of $17.70 per share. After the purchase, Mr. Shelnutt directly owns 11,626 shares. The filing also states he indirectly owns 5,074 shares through a 401(k) plan, and that some direct holdings include reinvested dividends and salary deferral. The form was signed by an attorney-in-fact on 09/24/2025. This filing reports a routine, small-dollar open-market purchase by a company officer and details ownership breakdown between direct and indirect holdings.

Positive

• Officer bought shares, aligning personal and shareholder interests with a purchase at $17.70
• Clear ownership breakdown showing direct (11,626) and indirect (5,074) holdings
• Disclosure includes explanations that shares include reinvested dividends, salary deferral, and 401(k) company match

Negative

• []

Insights

Financial Analyst

TL;DR: Small insider purchase by CFO; immaterial to valuation but aligns officer interests with shareholders.

The 25-share purchase at $17.70 is a de minimis transaction relative to the reported direct holding of 11,626 shares and indirect 5,074 shares. There are no derivative transactions disclosed. The filing confirms ownership through salary deferral, dividend reinvestment, and 401(k) match, indicating routine compensation-related accumulation rather than a material strategic buy. Impact on market or valuation is negligible.

Corporate Governance Expert

TL;DR: Filing is a standard Section 16 disclosure with no governance red flags.

The Form 4 is properly completed showing relationship (CFO), transaction date, amount and price, and includes explanatory remarks about reinvestment and 401(k) holdings. It was executed by an attorney-in-fact and signed on 09/24/2025. There are no indications of unusual or coordinated transactions requiring further governance scrutiny.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Shelnutt Derek

(Last) (First) (Middle)

115 S GRANT STREET

(Street)

FITZGERALD GA 31750

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLONY BANKCORP INC [ CBAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COLONY BANKCORP, INC COMMON STOCK	09/23/2025		A		25	A	$17.7	11,626(1)	D
COLONY BANKCORP, INC COMMON STOCK								5,074(2)	I	401k

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes shares acquired through reinvested dividends and salary deferral.

2. Includes shares acquired through 401k company match and reinvested dividends.

Remarks:

	Lee Bagwell, Attorney-in-fact for Derek Shelnutt	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the CBAN Form 4 report for Derek Shelnutt?

The Form 4 reports a purchase of 25 shares of COLONY BANKCORP common stock on 09/23/2025 at a price of $17.70 per share.

How many CBAN shares does the reporting person own after the transaction?

After the reported transaction, the filing shows 11,626 shares directly owned and 5,074 shares indirectly owned (through 401(k)).

What is Derek Shelnutt’s role at COLONY BANKCORP in this filing?

The filing identifies Derek Shelnutt as an Officer with the title CFO.

Were any derivative securities reported in this Form 4 for CBAN?

No derivative securities were reported; Table II shows no entries for options, warrants, or other derivatives.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Lee Bagwell, Attorney-in-fact for Derek Shelnutt on 09/24/2025.